Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Colossal Biosciences Inc. is an American biotechnology and genetic engineering company working to de-extinct several extinct animals, including the woolly mammoth, the Tasmanian tiger, the dire wolf, the dodo, the moa and the bluebuck. In 2023, it stated that it wants to have woolly mammoth hybrid calves by 2028, and wants to reintroduce them to the…
Technology, History, Science & Companies
Explore the main themes, entities and connections around Colossal Biosciences. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
colossal announced species elephant company project mammoth conservation genome genetic 2025 wolf asian 2023 dna dire woolly technology first extinct
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Colossal Biosciences | Founded | 2021; 5 years ago (2021) | 1.00 | infobox |
| Colossal Biosciences | Founders | George Church | 1.00 | infobox |
| Colossal Biosciences | Founders | Ben Lamm | 1.00 | infobox |
| Colossal Biosciences | Headquarters | Dallas, Texas, U.S. | 1.00 | infobox |
| Colossal Biosciences | Industry | Biotechnology | 1.00 | infobox |
| Colossal Biosciences | Key people | Ben Lamm (CEO) | 1.00 | infobox |
| Colossal Biosciences | Key people | Beth Shapiro (CSO) | 1.00 | infobox |
| Colossal Biosciences | Key people | Andrew Pask (Chief biology officer) | 1.00 | infobox |
| Colossal Biosciences | Number of employees | 170 (2025) | 1.00 | infobox |
| Colossal Biosciences | Total equity | 10.2B USD | 1.00 | infobox |
| Colossal Biosciences | Type | Private | 1.00 | infobox |
| Colossal Biosciences | Website | colossal.com | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.